arrow
E

Emily Han-Chung Hsiue

Howard Hughes Medical Institute
H指数:19
被引数:1,924

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements

双特异性抗体和靶向TP53突变相关新抗原的CAR T细胞显示出不同的亲和力需求

2026-01-160
OA
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities
2024-07-101
PRE
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

疏水相互作用主导了KRAS G12V新抗原的识别

2023-08-218
OAAI
Hybrid TCR-CAR design surpasses conventional CARs and patient-derived TCRs in targeting an ultra-low-density neoantigen
2023-04-140
PRE
TCR-mimic bispecific antibodies to target the HIV-1 reservoir

TCR模拟双特异性抗体靶向HIV-1库

2022-04-0816
OAAI
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

靶向HLA限制性新抗原的嵌合抗原受体的结构工程

2021-09-0625
OAAI
Targeting public neoantigens for cancer immunotherapy
2021-05-1793
OAAI
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
2021-05-1761
OA
Targeting loss of heterozygosity for cancer-specific immunotherapy

靶向杂合性缺失的癌症特异性免疫治疗

2021-03-1751
OAAI
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers
2021-03-1040
OA
Bispecific antibodies targeting mutant RAS neoantigens
2021-03-04122
OAAI
Targeting a neoantigen derived from a common TP53 mutation
Science
IF45.8
2021-01-010
OA